10.1002/ejoc.201701595
European Journal of Organic Chemistry
FULL PAPER
water); 1H NMR (400 MHz, DMSO-d6) δ 8.21 (d, J=8.4 Hz, 2H), 8.14 (d,
J=7.2 Hz, 1H), 7.70 (d, J=8.4 Hz, 2H), 7.62 (t, J=7.2 Hz, 1H), 7.54 (d,
J=7.2 Hz, 1H), 6.75 (d, J=8.4 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ
165.7, 139.0, 137.3, 134.2, 133.6, 131.5, 131.4, 130.2, 127.4, 116.0,
115.4. Anal. Calcd for C13H10ClIO3: C, 41.46; H, 2.68; I, 33.70. Found: C,
41.56; H, 2.54; I, 33.82.
General procedure for the syntesis of 5-nitro-1-aryl-1,2-
benziodoxol-3-(1H)-ones (7 i-k)
Suspension of 5-nitro-2-iodosobenzoic acid 8 (309 mg, 1 mmol) in DCM
(8 mL) was added to trifluoromethanesulfonic acid (2 equiv, 0.18 mL) at -
30oC. Reaction mixture was stirred for 10 min, then arene (0.3 mL) was
added. The magnetic stirring of the resulting mixture was continued
overnight at room temperature. Then reaction mixture was washed with
water (3x5 mL). The organic layer was separated, the organic extracts
were combined, dried with Na2SO4, the solvent was evaporated and the
crystalline product was dried in vacuum. Additional purification of
products 7i-k can be performed by crystallization from water.
5-Bromo-1-(4-methylphenyl)-1,2-benziodoxol-3-(1H)-one (7e). The
reaction of 5-bromo-2-iodobenzoic acid 6b (327 mg, 1.0 mmol), Oxone
(400 mg, 0.65 mmol), H2SO4 (total 0.8 mL) and toluene (0.3 mL)
according to the general procedure afforded 371 mg (89%) of product 7e,
isolated as white crystals; mp 215-216 oC (from ethanol-water 1:1) 1H
NMR (300 MHz, CDCl3-CD3OD 10:1) δ 8.32 (d, J=2.4, 1H), 7.74 (d,
J=8.1 Hz, 2H), 7.40 (dd, J=2.4,8.7 Hz, 2H), 7.30 (d, J=8.4 Hz, 2H), 6.49
(d, J=8.7 Hz, 1H), 2.40 (s, 3H).13C NMR (75 MHz, CDCl3) δ 166.4, 144.2,
137.0, 136.6, 135.4, 134. 8, 132.9, 128.1, 125.8, 113.2, 109.7, 21.6.
HRMS (TOF, ES+) m/z: [M+H]+ Calcd. for C14H11O2BrI: 416.8987; Found:
416.8975.
5-Nitro-1-(4-methylphenyl)-1,2-benziodoxol-3-(1H)-one
(7i).
The
reaction of 5-nitro-2-iodosobenzoic acid 8 (309 mg, 1.0 mmol), triflic acid
(0.18 mL), and toluene (0.3 mL) according to the general procedure
afforded 7j 214 mg (56%) of product 7i, isolated as white crystals; mp
213-215 oC 1H NMR (300 MHz, CDCl3) δ 8.99 (d, J=2.7 Hz, 1H), 8.13 (dd,
J=2.7, 9.0 Hz, 1H), 7.93 (d, J=8.1 Hz, 2H), 7.43 (d, J=7.8 Hz, 2H), 6.95 (d,
J=9.0 Hz, 1H), 2.54 (s, 3H). 13C NMR (75 MHz, CDCl3-CD3OD 2:1) δ
165.8, 150.0, 144.4, 136.8, 135.4, 133.0, 128.4, 127.4, 126.4, 121.0,
110.3, 21.4. HRMS (TOF, ES+) m/z: [M+H]+ Calcd. for C14H11NO4I:
383.9733; Found: 383.9727.
5-Bromo-1-(2,5-dimethylphenyl)-1,2-benziodoxol-3-(1H)-one (7f). The
reaction of 5-bromo-2-iodobenzoic acid 6b (327 mg, 1.0 mmol), Oxone
(400 mg, 0.65 mmol), H2SO4 (total 0.8 mL) and p-xylene (0.3 mL)
according to the general procedure afforded 228 mg (53%) of product 7f,
isolated as white crystals; mp 213-214 oC (from ethanol-water 1:1). 1H
NMR (400 MHz, CDCl3) δ 8.47 (d, J=2.4, 1H), 7.83 (s, 1H), 7.47-7.43 (m,
3H), 7.50 (d, J=8.8 Hz, 1H), 2.49 (s, 3H), 2.39 (s, 3H). 13C NMR (100
MHz, CDCl3) δ 165.9, 139.7, 139.0, 136.6, 136.4, 135.9, 135.7, 134.5,
131.3, 127.5, 126.0, 118.4, 113.0, 24.7, 20.8. HRMS (TOF, AP+) m/z:
[M+H]+ Calcd. for C15H13O2BrI: 430.9144; Found: 430.9150.
5-Nitro-1-(2,5-dimethylphenyl)-1,2-benziodoxol-3-(1H)-one (7j). The
reaction of 5-nitro-2-iodosobenzoic acid 8 (309 mg, 1.0 mmol), triflic acid
(0.18ml), p-xylene (0.3 mL) according to the general procedure afforded
246 mg (62%) of product 7j, isolated as white crystals; mp 208-209 oC.
1H NMR (300 MHz, CDCl3-CD3OD 5:1) δ 8.90 (d, J=2.7 Hz, 1H), 8.06 (dd,
J=2.7, 9.0 Hz, 1H), 7.69 (s, 1H), 7.38-7.32 (m, 2H), 6.77 (d, J=8.7 Hz,
1H), 2.33 (s, 3H), 2.24 (s, 3H). 13C NMR (100 MHz, CDCl3-CD3OD 10:1)
δ 165.9, 150.1, 139.9, 139.2, 138.5, 135.8, 134.7, 131.3, 127.9, 127.6,
126.7, 119.8, 117.9, 24.1, 20.3. HRMS (TOF, ES+) m/z: [M+H]+ Calcd.
for C15H13NO4I: 397.9889; Found: 397.9880.
5-Bromo-1-(2,4,6-trimethylphenyl)-1,2-benziodoxol-3-(1H)-one (7g).
The reaction of 5-bromo-2-iodobenzoic acid 6b (327 mg, 1.0 mmol),
Oxone (400 mg, 0.65 mmol), H2SO4 (total 0.8 mL) and mesitylene (0.3
mL) according to the general procedure afforded 275 mg (62%) of
product 7g, isolated as white crystals; mp 221-223 oC (from ethanol-
water 1:1) 1H NMR (500 MHz, CDCl3 – (CD3)2CO 1:5) δ 8.35 (d, J=2.5,
1H), 7.34 (dd, J=2.5, 8.0 Hz, 1H), 7.07 (s, 2H), 6.42 (d, J=8.5 Hz, 1H),
2.45 (s, 6H), 2.34 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 166.1, 144.0,
143.6, 136.4, 136.0, 130.0, 126.6, 125.9, 119.4, 112.6, 26.6, 21.5. HRMS
(TOF, ES+) m/z: [M+H]+ Calcd. for C16H15O2BrI: 444.9300; Found:
444.9303.
5-Nitro-1-(2,4,6-trimethylphenyl)-1,2-benziodoxol-3-(1H)-one
(7k).
The reaction of 5-nitro-2-iodosobenzoic acid 8 (309 mg, 1.0 mmol), triflic
acid (0.18 mL), p-xylene (0.3 mL) according to the general procedure
afforded 312 mg (76%) of product 7k, isolated as white crystals; mp 227-
228 oC. 1H NMR (300 MHz, CDCl3-CD3OD 2:1) δ 9.02 (d, J=2.7 Hz, 1H),
8.25 (dd, J=2.7, 8.7Hz, 1H) , 7.27 (s, 2H), 6.97 (d, J=8.7 Hz, 1H), 2.54 (s,
6H), 2.44 (s, 3H). 13C NMR (100 MHz, CDCl3-CD3OD 2:1) δ 167.2, 151.0,
145.4, 144.1, 137.2, 130.9, 130.7, 128.6, 127.4, 120.03, 119.98, 26.6,
21.5. HRMS (TOF, AP+) m/z: [M+H]+ Calcd. for C16H15NO4I: 412.0046;
Found: 412.0031.
5-Bromo-1-(4-chlorophenyl)-1,2-benziodoxol-3-(1H)-one (7h). The
reaction of 5-bromo-2-iodobenzoic acid 6b (327 mg, 1.0 mmol), Oxone
(400 mg, 0.65 mmol), H2SO4 (total 0.8 mL) and chlorobenzene (0.3 mL)
according to the general procedure afforded 175 mg (40%) of product 7h,
isolated as white crystals; mp 237-238 oC (from methanol-water 1:1). 1H
NMR (400 MHz, DMSO-d6) δ 8.22(d, J=8.4 Hz, 2H), 8.17 (s, 1H), 7.73-
7.70 (m, 3H), 6.66 (d, J=8.4 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ
164.2, 138.9, 137.5, 136.4, 136.0, 133.6, 131.5, 129.5, 124.1, 114.9,
114.8. HRMS (TOF, ES+) m/z: [M+H]+ Calcd. for C13H8O2ClBrI: 436.8441,
found: 436.8448.
General procedure for the synthesis of 2-azidobenzoic acid
(9)
1-Arylbenziodoxolones 7 (0.2 mmol) and NaN3 (68 mg, 1 mmol) were
mixed with DMSO (1 mL) and the resulting mixture was heated at 80 oC.
Then the reaction mixture was diluted with water (5 mL) and washed with
CH2Cl2 (3x5 mL). Hydrochloric acid was added to the reaction mixture
until acidic pH. Obtained azide was isolated by extraction with CH2Cl2
(3x5 mL). The organic extracts were dried with Na2SO4, the solvent was
evaporated and the crystalline product 9 (as an acid) was dried in
vacuum.
5-Nitro-2-iodosobenzoic acid (8). Following a reported procedure[9]
,
nitric acid (1.5 mL) was added to 2-iodobenzoic acid 6a (1.0 g, 4.03
mmol, 1 equiv) in concentrated H2SO4 (4.5 mL). The reaction flask was
equipped with a condenser and was heated at 100 °C for 2 h. The
reaction mixture was then poured in ice-water and filtered. The resulting
solid was refluxed in water (50 mL) for 1.5 h and then filtered and
washed with acetone (10 mL) to afford product 8 (1.11 g, 3.58 mmol,
89 %). 1H NMR (300 MHz, CDCl3) δ 8.83 (d, J=2.7 Hz, 1H), 8.30 (d, J=
8.7 Hz, 1H), 8.04 (dd, J=2.7, 8.7 Hz, 1H).
5-Bromo-2-azidobenzoic acid (9b). The reaction mixture of 1-
arylbenziodoxolone 7h (87 mg, 0.2 mmol), NaN3 (68 mg, 1 mmol) and
dry DMSO (1 mL) was heated for 5 h according to the general procedure
affording 34 mg (70%) of product 9b, isolated as white crystals; mp 148-
150 oC. 1H NMR (400 MHz, CDCl3) δ 8.20 (s, 1H), 7.70 (d, J=8.4 Hz, 1H),
7.16 (d, J=8.8 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 167.48, 139.63,
137.33, 135.98, 122.31, 121.41, 117.86.
This article is protected by copyright. All rights reserved.